Smartleaf Asset Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$170K Hold
317
0.01% 904
2026
Q1
$146K Sell
317
-82
-21% -$42K 0.01% 930
2025
Q4
$227K Sell
399
-204
-34% -$116K 0.01% 754
2025
Q3
$302K Buy
603
+11
+2% +$4.8K 0.02% 603
2025
Q2
$184K Sell
592
-91
-13% -$27.3K 0.02% 606
2025
Q1
$213K Sell
683
-69
-9% -$23.2K 0.02% 549
2024
Q4
$251K Sell
752
-171
-19% -$58K 0.03% 479
2024
Q3
$306K Buy
923
+123
+15% +$46.7K 0.04% 380
2024
Q2
$339K Buy
800
+82
+11% +$32.5K 0.06% 299
2024
Q1
$290K Buy
718
+8
+1% +$2.81K 0.06% 288
2023
Q4
$221K Buy
+710
New +$192K 0.06% 304

Other funds holding MEDP

Smartleaf Asset Management's MEDP Position: Q2 2026 in Review

Smartleaf Asset Management held its Medpace (MEDP) position steady in Q2 2026 at 317 shares worth $170K. The position accounts for 0.01% of the portfolio, ranked #904.

Smartleaf Asset Management first reported a position in MEDP in Q4 2023 and has held it in 11 quarters since. The position peaked at $339K in Q2 2024. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Smartleaf Asset Management held 317 shares of Medpace worth $170K as of Q2 2026.
  • Smartleaf Asset Management left its Medpace share count unchanged in Q2 2026.
  • Medpace made up 0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #904 holding.
  • Smartleaf Asset Management first reported a position in Medpace in Q4 2023 and has held it in 11 quarters since.
  • Smartleaf Asset Management's Medpace position peaked at $339K in Q2 2024.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.